These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 190146)
1. Appearance of Epstein-Barr virus nuclear antigen in human cordblood lymphocytes. Wright J; Falk L; Deinhardt F IARC Sci Publ (1971); 1975; (11 Pt 1):409-14. PubMed ID: 190146 [TBL] [Abstract][Full Text] [Related]
2. Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV). Yata J; Desgranges C; Nakagawa T; Favre MC; De-The G Int J Cancer; 1975 Mar; 15(3):377-84. PubMed ID: 49325 [TBL] [Abstract][Full Text] [Related]
3. Induction of Epstein-Barr virus-associated nuclear antigen during in vitro transformation of human lymphoid cells. Leibold W; Flanagan TD; Menezes J; Klein G J Natl Cancer Inst; 1975 Jan; 54(1):65-8. PubMed ID: 163326 [TBL] [Abstract][Full Text] [Related]
4. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos). Takimoto T; Sato H; Ogura H Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases. Joncas JH; Wills A; Reece E; Fox Z Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957 [TBL] [Abstract][Full Text] [Related]
6. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides. Meerbach A; Friedrichs C; Thust R; Wutzler P Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Epstein-Barr virus transformation: evidence for a block between EBNA production and cell proliferation. Pope JH; Moss DJ IARC Sci Publ (1971); 1978; (24 Pt 2):617-22. PubMed ID: 221385 [TBL] [Abstract][Full Text] [Related]
8. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains. Fresen KO; Hausen H Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026 [TBL] [Abstract][Full Text] [Related]
9. Induction of nuclear antigen (EBNA) synthesis without transformation in human cord lymphocytes by P3HR-1 strain of Epstein-Barr virus. Yamamoto N; Hinuma Y Virology; 1978 Sep; 89(2):623-6. PubMed ID: 213884 [No Abstract] [Full Text] [Related]
10. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells. zur Hausen H; Fresen KO IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation. Menezes J; Jondal M; Leibold W; Dorval G Infect Immun; 1976 Feb; 13(2):303-10. PubMed ID: 177360 [TBL] [Abstract][Full Text] [Related]
12. Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia. Sairenji T; Spiro RC; Reisert PS; Paquin L; Sakamoto K; Shibuya A; Sullivan JL; Katayama I; Humphreys RE Am J Hematol; 1983 Dec; 15(4):361-74. PubMed ID: 6316777 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells. Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685 [TBL] [Abstract][Full Text] [Related]
15. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8. Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis. Takada K; Osato T Intervirology; 1979; 11(1):30-9. PubMed ID: 218892 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of Epstein-Barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in Ramos cells. Fresen KO; Cho MS; zur Hausen H Int J Cancer; 1978 Aug; 22(2):160-5. PubMed ID: 81181 [TBL] [Abstract][Full Text] [Related]
18. Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease. Rabin H; Neubauer RH; Hopkins RF; Dzhikidze EK; Shevtsova ZV; Lapin BA Intervirology; 1977; 8(4):240-9. PubMed ID: 194867 [TBL] [Abstract][Full Text] [Related]
19. Interaction of the B95-8 and P3HR-1 substrains of Epstein-Barr virus (EBV) with peripheral human lymphocytes. Steinitz M; Bakács T; Klein G Int J Cancer; 1978 Sep; 22(3):251-7. PubMed ID: 212371 [TBL] [Abstract][Full Text] [Related]
20. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV. Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]